US EditionGallant Pursues FDA Approval, Names Dr. Rebecca Windsor Director of Veterinary Affairs
Summary by petage.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Gallant Pursues FDA Approval, Names Dr. Rebecca Windsor Director of Veterinary Affairs
Gallant, an animal health biotechnology company pioneering off-the-shelf stem cell therapies for pets, has announced that Rebecca Windsor, DVM, DACVIM, has joined the company as director of veterinary affairs. Dr. Windsor will lead Gallant’s veterinary education initiatives as the company pursues FDA approval for its ready-to-use stem cell therapy for refractory Feline Chronic Gingivostomatitis (FCGS). A board-certified veterinary neurologist wi…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
